Delisting risk
MDxHealth
Molecular prostate-cancer tests for testing and treatment decisions.
$0.7000
After-hours close−0.02 (−2.87%)
At close$0.7207(−0.11%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | −$0.19 | −$0.18 | +6.9% |
| May 2026 | −$0.14 | −$0.19 | −31.4% |
| Nov 2025 | −$0.12 | −$0.16 | −33.3% |
| Aug 2025 | −$0.13 | −$0.15 | −15.4% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | |||
| May 2025 | |||
| Feb 2025 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Mar 2022 | |||
| Aug 2021 | −$1.30 | — | — |
| Mar 2021 | −$1.50 | — | — |
| Dec 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Dec 2018 | |||
| Jun 2018 | |||
| Dec 2017 | |||
| Jun 2017 | |||
| Dec 2016 | |||
| Jun 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Dec 2014 | |||
| Jun 2014 | |||
| Dec 2013 | |||
| Jun 2013 | |||
| Dec 2012 | |||
| Jun 2012 | |||
| Dec 2011 | |||
| Jun 2011 | |||
| Dec 2010 | |||
| Jun 2010 | |||
| Dec 2009 | |||
| Jun 2009 | |||
| Dec 2008 | |||
| Jun 2008 | |||
| Dec 2007 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | −$0.19 | −$0.18 | +6.9% | $26.1M | $27.2M | +4.1% |
| May 13, 2026 | −$0.14 | −$0.19 | −31.4% | $30.9M | $23.9M | −22.6% |
| Nov 12, 2025 | −$0.12 | −$0.16 | −33.3% | $26.2M | $53.2M | +103.2% |
| Aug 5, 2025 | −$0.13 | −$0.15 | −15.4% | $26.3M | $26.6M | +1.1% |
The latest year is open to everyone — the 42 quarters behind it read with an account. Sign in | ||||||
| May 14, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Aug 21, 2024 | ||||||
| May 1, 2024 | ||||||
| Mar 6, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 23, 2023 | ||||||
| May 15, 2023 | ||||||
| Mar 8, 2023 | ||||||
| Oct 27, 2022 | ||||||
| Aug 25, 2022 | ||||||
| Apr 27, 2022 | ||||||
| Mar 2, 2022 | ||||||
| Aug 26, 2021 | −$1.30 | — | — | $12.0M | — | — |
| Mar 3, 2021 | −$1.50 | — | — | $8.8M | — | — |
| Dec 31, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Dec 31, 2017 | ||||||
| Jun 30, 2017 | ||||||
| Dec 31, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Jun 30, 2015 | ||||||
| Dec 31, 2014 | ||||||
| Jun 30, 2014 | ||||||
| Dec 31, 2013 | ||||||
| Jun 30, 2013 | ||||||
| Dec 31, 2012 | ||||||
| Jun 30, 2012 | ||||||
| Dec 31, 2011 | ||||||
| Jun 30, 2011 | ||||||
| Dec 31, 2010 | ||||||
| Jun 30, 2010 | ||||||
| Dec 31, 2009 | ||||||
| Jun 30, 2009 | ||||||
| Dec 31, 2008 | ||||||
| Jun 30, 2008 | ||||||
| Dec 31, 2007 | ||||||